EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Unveiling the potential of copper-61 vs. gallium-68 for SSTR PET imaging

A I Fonseca iD, J Sereno iD, S Almeida iD, H Ferreira iD, I Hrynchak iD, A Falcão iD, F Alves iD, C Gomes iD, A J Abrunhosa iD

European Journal of Nuclear Medicine and Molecular Imaging · 2025

DOI: 10.1007/s00259-025-07116-2 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von A I Fonseca und 8 weiteren Autor:innen. Beteiligte Einrichtung: ICNAS Pharma, University of Coimbra, Coimbra, Portugal. Hauptthemen laut MEDLINE: Gallium Radioisotopes, Copper Radioisotopes, Positron-Emission Tomography, Receptors, Somatostatin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade de Coimbra.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

In recent years, copper-61 has attracted considerable attention from both physicists and radiochemists due to its favorable physical decay properties for PET imaging and its ease of production at any cyclotron center producing [ 18 F]FDG. The aim of this study was to evaluate the potential of 61 Cu-based radiopharmaceuticals for PET imaging of NETs, as an alternative to the commonly used gallium-68.

Methods

Copper-61 was produced by irradiation of natural zinc liquid targets, followed by post-processing. In vitro evaluation of 61 Cu- and 68 Ga-labeled SST analogues was performed in SSTR positive AR42J tumor cells. PET/MRI was carried out in mice bearing AR42J subcutaneous tumors.

Results

High molar activity [ 61 Cu]Cu-DOTA-TATE and [ 61 Cu]Cu-NOTA-TATE were successfully prepared with a radiochemical purity of over 95% and were shown to be stable for at least 6 h after the EOS. Both 61 Cu- and 68 Ga-labeled SST analogues exhibited high cellular uptake, with residual uptake when blocked with an excessive amount of peptide precursor. [ 61 Cu]Cu-NOTA-TATE showed the highest tumor uptake at 1 h p.i. (13.25 ± 1.86%ID/g) and the tumor-to-non-tumor ratio increased from 1 h to 4 h p.i. At the later time point, tumor visualization improved compared to 1 h p.i. Moreover, preclinical PET/MR images demonstrated that [ 61 Cu]Cu-NOTA-TATE has a more favorable biodistribution and imaging properties than [ 61 Cu]Cu-DOTA-TATE, with the extended PET imaging window providing a clear advantage of [ 61 Cu]Cu-NOTA-TATE over its gallium-68 analogues. Conclusion [ 61 Cu]Cu-NOTA-TATE showed similar biodistribution and pharmacokinetics to [ 68 Ga]Ga-DOTA-TATE at 1 h p.i., while demonstrating superior imaging characteristics for late PET imaging. These findings demonstrate that [ 61 Cu]Cu-NOTA-TATE holds promising characteristics for improving the detection of NETs with increased translational potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallium RadioisotopesCopper RadioisotopesPositron-Emission TomographyReceptors, SomatostatinRadiopharmaceuticalsAnimalsMiceCell Line, TumorTissue DistributionHumans

Stichwörter der Autor:innen

Copper-61DOTA-TATENETsNOTA-TATEPET

Substanzen

Gallium RadioisotopesCopper RadioisotopesGallium-68Receptors, SomatostatinRadiopharmaceuticals

Autor:innen und Institutionen

  • ICNAS Pharma, University of Coimbra, Coimbra, Portugal.
  • CIBIT/ICNAS, Institute for Nuclear Science Applied to Health, University of Coimbra, Coimbra, Portugal.
  • Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Center for Innovative Biomedicine and Biotechnology Consortium (CIBB), University of Coimbra, Coimbra, Portugal.
  • Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal.
  • ESTeSC - Coimbra Health School, Instituto Politécnico Coimbra, Coimbra, Portugal.

ORCID-Profile: A I Fonseca, J Sereno, S Almeida, H Ferreira, I Hrynchak, A Falcão, F Alves, C Gomes, A J Abrunhosa

Förderung

  • Universidade de Coimbra

Zitieren

APA

Fonseca, A. I., Sereno, J., Almeida, S., Ferreira, H., Hrynchak, I., Falcão, A., Alves, F., Gomes, C., & Abrunhosa, A. J. (2025). Unveiling the potential of copper-61 vs. gallium-68 for SSTR PET imaging. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07116-2

Vancouver

Fonseca AI, Sereno J, Almeida S, Ferreira H, Hrynchak I, Falcão A, et al. Unveiling the potential of copper-61 vs. gallium-68 for SSTR PET imaging. European Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.1007/s00259-025-07116-2

BibTeX
@article{Fonseca2025,
  author = {Fonseca, A I and Sereno, J and Almeida, S and Ferreira, H and Hrynchak, I and Falcão, A and Alves, F and Gomes, C and Abrunhosa, A J},
  title = {Unveiling the potential of copper-61 vs. gallium-68 for SSTR PET imaging},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2025},
  doi = {10.1007/s00259-025-07116-2}
}
Kostenlos starten →